Old Web
English
Sign In
Acemap
>
authorDetail
>
Xiao Ma
Xiao Ma
Eli Lilly and Company
Medicine
Health care
Clinical trial
Demography
Regorafenib
2
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Quality of life and treatment satisfaction with pharmacological interventions in Chinese adults with chronic pain due to osteoarthritis.
2021
BMC Musculoskeletal Disorders
Qingyun Xue
Huibin Long
Jianhao Lin
Dongping Du
Jin Zhou
Jinwei Chen
Shu Li
Yanlei Zhang
Yan Cheng
Xiao Ma
Zhiyi Zhang
Show All
Source
Cite
Save
Citations (1)
Cost-effectiveness analysis of fruquintinib versus regorafenib as the third-line therapy for metastatic colorectal cancer in China.
2021
Journal of Medical Economics
Xin Guan
Hongchao Li
Xiaomo Xiong
Cike Peng
Ning Wang
Xiao Ma
Aixia Ma
Show All
Source
Cite
Save
Citations (2)
1